Table 1.
Key Model Parameters (Full methodological details are provided in Supplemental Technical Appendix) | |
---|---|
Weekly Screening Rates – Undiagnosed (All Races) | 1.28% |
Weekly Probability of Initiating ART - Diagnosed | |
Black | 12.5% |
Hispanic | 15.8% |
White | 16.4% |
Weekly Probability of Stopping ART – Treated by ART | |
Black | 0.09% |
Hispanic | 0.09% |
White | 0.084% |
Probability of Starting PrEP After a Negative HIV Test (All Races) | 68.5% |
Weekly Probability of Stopping PrEP While Eligible (All Races) | 2.6% |
Primary Scenarios (Increasing PrEP Coverage at Empirical ART Coverage) | |
ART Coverage1 (Proportion of Virally Suppressed2) | 88.2% (65.0%) † |
PrEP Coverage3 | |
Reference | 25% † |
Experimental | 37.5% to 75% (4 levels) |
Total: 5 scenarios (5 levels of PrEP over 1 level of ART) | |
Secondary Scenarios (Increasing PrEP Coverage at Counterfactual ART Coverage) | |
ART Coverage1 (Proportion of Virally Suppressed2) | |
Low ART | 75.1% (51.2%) |
Empirical ART | 88.2% (65.0%) † |
High ART | 99.5% (72.9%) |
PrEP Coverage3 | |
Reference | 0% * |
Experimental | 12.5% to 75% (6 levels) |
Total: 21 scenarios (7 levels of PrEP over 3 levels of ART Coverage) |
San Francisco calibrated values
Changes in PrEP coverage at a given ART Coverage is compared to 0% PrEP at the same ART Coverage
Proportion of ART users among individuals with diagnosed HIV infection
Proportion of HIV-infected MSM who are virally suppressed
Proportion of PrEP users among PrEP eligible at any time point